Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study. - Hanefeld,M.; Pfützner,A.; Forst,T. (Curr Med Res Op, 2006)